Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$99.26

-0.63 (-0.63%)

09:24
10/10/16
10/10
09:24
10/10/16
09:24

TESARO price target raised to $122 on Niraparib data at Credit Suisse

Credit Suisse analyst Alethia Young raised TESARO's price target to $122 from $90 after the company reported "clinically meaningful benefits in all the sub-populations" of the NOVA trial for niraparib. The analyst thinks niraparib has broad effects across the 2nd line ovarian population and would expect the label is broad. Young has an Outperform ratting n TESARO shares.

  • 06

    Nov

  • 11

    Jan

TSRO Tesaro
$99.26

-0.63 (-0.63%)

10/10/16
LTCO
10/10/16
DOWNGRADE
Target $16
LTCO
Sell
Myriad Genetics downgraded to Sell from Neutral at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter downgraded Myriad Genetics (MYGN) to Sell citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. The analyst expects a lower growth outlook to drive "significant P/E multiple compression." Tesaro (TSRO) presented data this weekend that suggested its PARP inhibitor niraparib was active in a maintenance setting for recurrent ovarian cancer in patients with either positive or negative HRD scores. The analyst had expected the drug to benefit only HRD positive patients. As such, the use of niraparib will not require HRD testing, DeGeeter tells investors in a research note. The analyst has a $16 price target for the shares.
10/10/16
PIPR
10/10/16
NO CHANGE
PIPR
Neutral
TESARO data suggest Myriad test not necessary, says Piper Jaffray
Piper Jaffray analyst William Quirk points out that data over the weekend from TESARO (TSRO), Myriad Genetics' (MYGN) companion diagnostic partner, suggest niraparib works in all-comers, making Myriad's test not necessary. Myriad shares may be down physiologically, Quirk tells investors in a research note partially titled "When A Partnership Produces Mixed Results." The analyst, however, believes niraparib is not clinically significant in HRD negative patients and that Myriad's test will be included on the drug label. He keeps a Neutral rating on shares of Myriad. Ladenburg Thalmann this morning downgraded the stock to Neutral.
10/10/16
LEER
10/10/16
NO CHANGE
Target $115
LEER
Outperform
TESARO price target raised to $115 after niraparib data at Leerink
Leerink analyst Seamus Fernandez said full results of TESARO's Phase 3 NOVA trial for niraparib as second-line maintenance for ovarian cancer presented at the ESMO meeting are strong enough to warrant approval in the overall patient population regardless of BRCAmut or HRD status. He increased his probability of approval in non-gBRCA/HRD-negative patients to 70% in the U.S., from 0%, and to 50% in the EU, from 0%. He raised his price target on TESARO shares to $115 from $108 per share and keeps an Outperform rating on the stock.
10/10/16
RAJA
10/10/16
NO CHANGE
Target $120
RAJA
Strong Buy
TESARO price target raised to $120 at Raymond James
Raymond James analyst Christopher Raymond raised TESARO's price target to $120 from $105 fter the company reported "clinically meaningful benefits in all the sub-populations" of the NOVA trial for niraparib. Raymond thinks niraparib will have a broad ovarian cancer label and corresponding market opportunity and reiterates his Strong Buy rating.

TODAY'S FREE FLY STORIES

FB

Facebook

$171.11

-1.06 (-0.62%)

14:53
09/22/17
09/22
14:53
09/22/17
14:53
Periodicals
Facebook settles lawsuit over non-voting shares, Business Insider reports »

Facebook settled a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

XOP

SPDR Oil Exploration and Production Fund

$33.00

0.09 (0.27%)

14:50
09/22/17
09/22
14:50
09/22/17
14:50
Options
SPDR Oil Exploration and Production ETF puts outpace calls 6:1 »

SPDR Oil Exploration and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTXI

GTx

$8.74

0.17 (1.98%)

14:48
09/22/17
09/22
14:48
09/22/17
14:48
Conference/Events
GTx, Inc to hold a KOL luncheon meeting »

Management hosts a KOL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXPE

Expedia

$143.12

0.11 (0.08%)

14:45
09/22/17
09/22
14:45
09/22/17
14:45
Options
Expedia call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$74.21

-7.54 (-9.22%)

14:35
09/22/17
09/22
14:35
09/22/17
14:35
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPPI

Spectrum

$9.81

-0.13 (-1.31%)

14:27
09/22/17
09/22
14:27
09/22/17
14:27
Hot Stocks
Spectrum lower after Twitter highlights failed trial in Korea »

Shares of Spectrum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DLPH

Delphi

$102.58

1.54 (1.52%)

14:21
09/22/17
09/22
14:21
09/22/17
14:21
Conference/Events
Delphi to hold investor update meeting »

Investor Update Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

$NSD

NASDAQ Market Internals

14:17
09/22/17
09/22
14:17
09/22/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/22/17
09/22
14:16
09/22/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVX

Chevron

$117.03

0.56 (0.48%)

14:15
09/22/17
09/22
14:15
09/22/17
14:15
Options
Chevron put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 09

    Nov

S

Sprint

$8.42

0.39 (4.86%)

, TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

14:12
09/22/17
09/22
14:12
09/22/17
14:12
Periodicals
Sprint hired lobbyist tied to Trump in September, Reuters says »

Sprint (S) hired a…

S

Sprint

$8.42

0.39 (4.86%)

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 16

    May

OPK

OPKO Health

$6.48

0.15 (2.37%)

14:05
09/22/17
09/22
14:05
09/22/17
14:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

14:05
09/22/17
09/22
14:05
09/22/17
14:05
General news
Dallas Fed hawk Kaplan is open minded about one more hike »

Dallas Fed hawk Kaplan is…

GWRE

Guidewire

$78.42

1.26 (1.63%)

14:04
09/22/17
09/22
14:04
09/22/17
14:04
Conference/Events
Guidewire to host analyst day »

Analyst Day to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

, WPG

Washington Prime

$8.13

0.095 (1.18%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Recommendations
Four Corners Property Trust, Washington Prime analyst commentary  »

Four Corners Property…

FCPT

Four Corners Property Trust

$25.05

-0.27 (-1.07%)

WPG

Washington Prime

$8.13

0.095 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

, UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

14:02
09/22/17
09/22
14:02
09/22/17
14:02
Hot Stocks
Health insurers jump as McCain comes out against latest repeal/replace effort »

Shares of a number of…

MOH

Molina Healthcare

$61.75

-0.76 (-1.22%)

UNH

UnitedHealth

$188.70

-6.51 (-3.33%)

CNC

Centene

$87.58

-3.16 (-3.48%)

WCG

WellCare

$163.07

-2.99 (-1.80%)

CI

Cigna

$181.14

-0.99 (-0.54%)

ANTM

Anthem

$181.21

-2.29 (-1.25%)

HNT

Health Net

HUM

Humana

$235.79

-2.85 (-1.19%)

AET

Aetna

$150.76

-2.63 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

ICPT

Intercept

$73.70

-24.42 (-24.89%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Downgrade
Intercept rating change  »

Oppenheimer downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAL

American Airlines

$46.29

0.87 (1.92%)

13:57
09/22/17
09/22
13:57
09/22/17
13:57
Hot Stocks
Trump thanks American Airlines for 'fantastic job' with hurricane flights »

President Donald Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

, RUT

Russell 2000 Index

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Technical Analysis
On The Fly: Weekly technical notes for Russell 2000 »

The Russell 2000 (RUT) is…

IWM

iShares Trust Russell 2000 Index Fund

$144.38

0.69 (0.48%)

RUT

Russell 2000 Index

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

, UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

13:53
09/22/17
09/22
13:53
09/22/17
13:53
Periodicals
McCain says cannot vote for Graham-Cassidy healthcare bill, Bloomberg reports »

Publicly traded companies…

MOH

Molina Healthcare

$61.77

-0.74 (-1.18%)

UNH

UnitedHealth

$189.08

-6.13 (-3.14%)

CNC

Centene

$87.61

-3.13 (-3.45%)

WCG

WellCare

$162.70

-3.36 (-2.02%)

CI

Cigna

$181.18

-0.9483 (-0.52%)

ANTM

Anthem

$181.24

-2.26 (-1.23%)

HNT

Health Net

HUM

Humana

$235.91

-2.735 (-1.15%)

AET

Aetna

$150.81

-2.58 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

, XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

13:51
09/22/17
09/22
13:51
09/22/17
13:51
Technical Analysis
On The Fly: Weekly technical notes for S&P 500 »

For the week, the S&P…

XLE

Energy Select Sector SPDR

$67.08

0.22 (0.33%)

XLI

Industrial Select Sector SPDR

$70.76

0.19 (0.27%)

XLF

Financial Select Sector

$25.43

-0.035 (-0.14%)

XLB

S&P Select Materials SPDR

$56.57

-0.18 (-0.32%)

XLP

Consumer Staples Sector SPDR

$53.97

-0.115 (-0.21%)

XLU

Utilities SPDR

$53.43

-0.24 (-0.45%)

XLV

Health Care Select Sector SPDR

$81.25

-0.33 (-0.40%)

SPY

SPDR S&P 500 ETF Trust

$249.16

-0.23 (-0.09%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.07

0.16 (0.30%)

, UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Periodicals
Total sells Total Italia Gas to UGI Corporation, Reuters reports »

Total (TOT) has sold its…

TOT

Total

$54.07

0.16 (0.30%)

UGI

UGI Corporation

$47.06

-0.28 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$21.56

0.3975 (1.88%)

13:50
09/22/17
09/22
13:50
09/22/17
13:50
Options
One-week option play opened in Macy's »

One-week option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ICPT

Intercept

13:48
09/22/17
09/22
13:48
09/22/17
13:48
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXAS

Exact Sciences

$45.00

1.6 (3.69%)

13:40
09/22/17
09/22
13:40
09/22/17
13:40
Options
Longer-term spread opened in Exact Sciences »

Longer-term spread opened…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.